WCM
Wildcat Capital Management Portfolio holdings
AUM
$168M
This Quarter Return
-29.97%
1 Year Return
-10.74%
3 Year Return
+57.92%
5 Year Return
+2.31%
10 Year Return
+525.89%
AUM
$187M
AUM Growth
+$187M
(-26%)
Cap. Flow
+$19.5M
Cap. Flow
% of AUM
10.4%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
10
New
2
Increased
–
Reduced
–
Closed
2
Top Buys
| 1 |
TIC
Acuren Corporation
TIC
|
$16.7M |
| 2 |
CNTA
Centessa Pharmaceuticals
CNTA
|
$4.05M |
Top Sells
| 1 |
GitLab
GTLB
|
$642K |
| 2 |
Procore
PCOR
|
$607K |
Sector Composition
| 1 | Industrials | 73.89% |
| 2 | Consumer Staples | 18.11% |
| 3 | Healthcare | 8% |
| 4 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Frontier Group Holdings
ULCC
$1.12B
| $122M | 64.99% | 28,061,351 | – | – |
|
2
RLX Technology
RLX
$3.09B
| $33.9M | 18.11% | 18,046,195 | – | – |
|
|
TIC
3
Acuren Corporation
TIC
$2.26B
| $16.7M | 8.9% | +1,500,000 | New | +$16.7M |
|
4
UroGen Pharma
URGN
$900M
| $5.48M | 2.93% | 495,606 | – | – |
|
5
Allogene Therapeutics
ALLO
$251M
| $4.26M | 2.28% | 2,920,787 | – | – |
|
|
CNTA
6
Centessa Pharmaceuticals
CNTA
$2.25B
| $4.05M | 2.16% | +281,859 | New | +$4.05M |
|
|
KRON
7
DELISTED
Kronos Bio
KRON
| $1.07M | 0.57% | 1,297,959 | – | – |
|
|
SLXN
8
Silexion Therapeutics Corp Ordinary Shares
SLXN
$5.36M
| $125K | 0.07% | 113,428 | – | – |
|
|
9
GitLab
GTLB
$7.93B
| – | – | -11,399 | Closed | -$642K |
|
|
10
Procore
PCOR
$10.4B
| – | – | -8,095 | Closed | -$607K |
|